Editors’ Picks, June 2024: Metabolic Imaging, Practice-changing Adagrasib Trial, and More
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
A recap of the plenary sessions, cutting-edge science, clinical trials, and more covered by the AACR blog.
The editors of AACR's journals highlight studies from May, including machine learning, savings from quitting smoking, and more.
Experience the annual undergraduate poster competition at the AACR Annual Meeting through photos.
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
A few important details to help attendees get the most out of their experience at the AACR Annual Meeting...
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
Three patients share their experiences about having Lynch syndrome.
Event cochair Dr. Michael Caligiuri shares how attendees can form connections to take science from bench to market.